MIRUM PHARMACEUTICALS INC (MIRM) Stock Income Statement
NASDAQ:MIRM - Nasdaq - US6047491013 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 379.25M | 336.89M | 186.37M | 77.06M | 19.14M | |||
| Cost Of Goods | 86.83M | 81.64M | 47.04M | 12.37M | 1.90M | |||
| Gross Profit | 292.42M | 255.25M | 139.34M | 64.69M | 17.24M | |||
| Operating Expenses | 368.74M | 342.85M | 248.49M | 195.91M | 190.65M | |||
| Research and Development | 154.45M | 140.63M | 102.61M | 106.84M | 131.43M | |||
| Selling, General, and Administrative Expenses | 214.29M | 202.22M | 145.88M | 89.07M | 59.22M | |||
| Operating Income | -76.32M | -87.61M | -109.15M | -131.22M | -173.41M | |||
| Interest Income/Expense | -1.15M | -519.00K | -1.37M | -11.22M | -17.96M | |||
| Other Income/Expense | 1.56M | 1.21M | -2.82M | 370.00K | -580.00K | |||
| Non Recurring Items | N/A | 0.00 | -49.08M | 0.00 | 108.00M | |||
| Income Before Taxes | -75.91M | -86.91M | -162.42M | -142.07M | -83.95M | |||
| Income Tax | 1.44M | 1.03M | 991.00K | -6.41M | 40.00K | |||
| Net Income | -77.34M | -87.94M | -163.41M | -135.67M | -83.99M | |||
| EBITDA | -52.30M | -63.98M | -98.33M | -127.98M | -172.81M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.61 | -1.85 | -4.00 | -4.01 | -2.77 | |||
| Non GAAP EPS | -1.61 | -1.85 | -3.97 | -4.02 | -6.35 | |||
| Statistics | ||||||||
| Gross Profit Margin | 77.10% | 75.77% | 74.76% | 83.95% | 90.07% | |||
| Profit Margin | -20.39% | -26.10% | -87.68% | -176.06% | -438.82% | |||
| Operating Profit Margin | -20.12% | -26.00% | -58.57% | -170.28% | -906.01% | |||
All data in USD